Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-04-07
1998-06-16
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242041, 4242051, 4241841, A61K 3112, A61K 39145, A61K 3900, A61K 3938
Patent
active
057666016
ABSTRACT:
This disclosure relates to methods and compositions for stimulating in an individual an influenza A virus protective response which is subtype cross-protective. Influenza A virus NS1 protein, or a T cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response.
REFERENCES:
patent: 4803072 (1989-02-01), Dalton et al.
Wraith et al., J. Gen Virol. 68:433-440 (1987).
Bennink et al., J. Gen. Virol. 61:1098-1102 (1987).
Yamada et al., J. Exp. Med. 162:663-674 (1985).
Kuwano et al., J. Exp. Med. 169:1361-1371 (1989).
Kuwano et al., J. Immunol. 140:1264-1268 (1988).
Kuwano and Ennis, Chemical Abstracts 113: Abstract No.:130459C p. 499 (1990).
Kingsman, Genetic Engineering Chapter 12, Blackwell Scientific Publications (Oxford, GB), 1988.
Young et al., "Efficient Expression of Influenza Virus NS1. . ." PNAS 80:6105-6109 (1983).
Smith et al., "Synthesis and Cellular Location of Ten Influenza. . ." Virology 160:336-345 (1987).
Shaw et al., "Immunologic Studies on the Influenza Virus" J. Exp. Med. 156:234-254 (1982).
Bennink, et al, 1987, Anh-Influenza virus cytotoxic T Iymphocytes. . . J. Virol. 61(4):1098-1102.
Kuwano, Koichi et al., "Cross-Reactive Protection against Influenza A Virus Infections," Virology,178 :174-179 (1990).
Cossins Judy et al., "Precise Prediction of a K.sup.k -Restricted Cytotoxic T Cell Epitope in the NS1 Protein of Influenza Virus Using an MHC Allele-Specific Motif," Virology,193 (1) :289-295 (1993).
Hackett, Charles J. et al. "Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope indentified in the NS1 non-structural protein," J. of General Virology,73:1339-1343 (1992).
Smith Lynette F.
University of Massachusetts Medical Center
LandOfFree
Cross-reactive influenza a immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-reactive influenza a immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive influenza a immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1722017